SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-010819
Filing Date
2018-08-13
Accepted
2018-08-13 16:07:58
Documents
84
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_immucellcorp.htm 10-Q 608039
2 CERTIFICATION f10q0618ex31_immucell.htm EX-31 9844
3 CERTIFICATION f10q0618ex32_immucell.htm EX-32 5276
  Complete submission text file 0001213900-18-010819.txt   4826071

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20180630.xml EX-101.INS 958843
5 XBRL SCHEMA FILE iccc-20180630.xsd EX-101.SCH 51906
6 XBRL CALCULATION FILE iccc-20180630_cal.xml EX-101.CAL 56808
7 XBRL DEFINITION FILE iccc-20180630_def.xml EX-101.DEF 155078
8 XBRL LABEL FILE iccc-20180630_lab.xml EX-101.LAB 490512
9 XBRL PRESENTATION FILE iccc-20180630_pre.xml EX-101.PRE 330203
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 181012330
SIC: 2835 In Vitro & In Vivo Diagnostic Substances